Incidence and Bacterial Etiologies of Surgical Site Infections in a Public Hospital, Addis Ababa, Ethiopia

Table 2: Antimicrobial susceptibility pattern of isolates from SSI in Yekatit 12 Hospital, Ethiopia.

Antibiotic discs (Oxoid, UK)	Susceptibility pattern	S. aureus (n=27)	Enterococcus spp (n=1)	Klepsiella spp (n=10)	E. coli (n=11)	Acinetobacter spp (n=2)	Citrobacter spp (n=1)	Proteus spp (n=1)	Enterobacter spp (2)
Penicillin, 10 units	S	3 (11.1)	0 (0)	NT	NT	NT	NT	NT	NT
Penicillin, 10 units	R	24 (88.9)	1 (100)	NT	NT	NT	NT	NT	NT
Erythromycin, 15 µg	S	22 (81.5)	NT	NT	NT	NT	NT	NT	NT
Erythromycin, 15 µg	R	5 (8.5)	NT	NT	NT	NT	NT	NT	NT
Clindamycin, 2 µg	S	23 (85.2)	NT	NT	NT	NT	NT	NT	NT
Clindamycin, 2 µg	R	4 (14.8)	NT	NT	NT	NT	NT	NT	NT
Cefoxitin, 30 µg	S	24 (88.9)	NT	NT	NT	NT	NT	NT	NT
Cefoxitin, 30 µg	R	3 (11.1)	NT	NT	NT	NT	NT	NT	NT
Vancomycin, 30 µg	S	27 (100)	1 (100)	NT	NT	NT	NT	NT	NT
Vancomycin, 30 µg	R	0 (0)	0 (0)	NT	NT	NT	NT	NT	NT
Gentamicin, 10 µg	S	27 (100)	NT	3 (30)	4 (36.4)	2 (100)	1 (100)	1 (100)	0 (0)
Gentamicin, 10 µg	R	0 (0)	NT	7 (70)	7 (63.6)	0 (0)	0 (0)	0 (0)	2 (100)
Trimethoprim/sulfamethoxazole, 1.25/23.75 µg	S	15 (55.6)	NT	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)
Trimethoprim/sulfamethoxazole, 1.25/23.75 µg	R	12 (44.4)	NT	10 (100)	11 (100)	2 (100)	1 (100)	1 (100)	2 (100)
Ciprofloxacin, 5 µg	S	26 (96.3)	0 (0)	1 (9)	4 (36.4)	1 (50)	0 (0)	1 (100)	1 (50)
Ciprofloxacin, 5 µg	R	1 (3.7)	1 (100)	9 (90)	7 (63.6)	1 (50)	1 (100)	0 (0)	1 (50)
Chloramphenicol, 30 µg	S	NT	1 (100)	0 (0)	2 (18.2)	0 (0)	0 (0)	NT	NT
Chloramphenicol, 30 µg	R	NT	0 (0)	10 (100)	9 (81.8)	2 (100)	1 (100)	NT	NT
Meropenem, 10 µg	S	NT	NT	10 (100)	11 (100)	2 (100)	1 (100)	1 (100)	2 (100)
Meropenem, 10 µg	R	NT	NT	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)
Cefepime, 30 µg	S	NT	NT	2 (8)	2 (18.2)	1 (50)	0 (0)	1 (100)	2 (100)
Cefepime, 30 µg	R	NT	NT	8 (80)	9 (81.8)	1 (50)	1 (100)	0 (0)	0 (0)
Ceftazidime, 30 µg	S	NT	NT	0 (0)	2 (18.2)	0 (0)	0 (0)	1 (100)	2 (100)
Ceftazidime, 30 µg	R	NT	NT	10 (100)	9 (81.8)	2 (100)	1 (100)	0 (0)	0 (0)
Amikacin, 30 µg	S	NT	NT	10 (100)	11 (100)	2 (100)	1 (100)	1 (100)	2 (100)
Amikacin, 30 µg	R	NT	NT	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)
Cefuroxime, 30 µg	S	NT	0 (0)	0 (0)	2 (18.2)	0 (0)	0 (0)	NT	0 (0)
Cefuroxime, 30 µg	R	NT	1 (100)	10 (100)	9 (81.8)	2 (100)	1 (100)	NT	2 (100)
Augmentin (amoxicillin/clavulanate, 20/10 µg)	S	NT	NT	0 (0)	2 (18.2)	0 (0)	0 (0)	1 (100)	0 (0)
Augmentin (amoxicillin/clavulanate, 20/10 µg)	R	NT	NT	10 (100)	9 (81.8)	2 (100)	1 (100)	0 (0)	2 (100)
Ampicillin, 10 µg	S	NT	NT	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)
Ampicillin, 10 µg	R	NT	NT	10 (100)	11 (100)	2 (100)	1 (100)	1 (100)	2 (100)